The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

A grandad caught up in the drugs trade yet again has said, "There won't be a third time". Paul Fleming, previously convicted as a drug courier, was found with over £70,000 hidden in his car at Switch ...

On March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate cancer. Just six days later, James ...

Common gut bacteria can metabolise some oral medications potentially rendering these important drugs against migraines, depression, type 2 diabetes, and prostate cancer less ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

The antibody-drug conjugate FOR46 showed the strong potential of using CD46 as a new therapeutic target in metastatic ...

Recovering erections grabs the attention of most men and their doctors after prostate cancer treatment. A new study redirects ...